Molecular Diagnostics

CLSI MM26 Webinar

Leading a Successful and Quality Molecular Oncology Laboratory: Actionable Guidance for Laboratory Directors and Supervisors from CLSI MM26

Watch this insightful webinar that delves into MM26 Cancer Molecular Testing: Principles of Oncology Test Interpretation. This session will cover laboratory and assay design, as well as clinical consultation. Discover how to build and grow a robust cancer testing program and explore strategies to maintain and enhance a cancer genomics laboratory. Our expert speakers will also discuss the latest advancements in oncology test interpretation and clinical consultation. 

Agenda

  • Oncology Test Interpretation and Clinical Consultation 
  • Building and Growing a Cancer Testing Program
  • Maintaining and Improving a Cancer Genomics Laboratory and New Frontiers in Testing
  • Panel Discussion
September 26, 2024
1.00

{{FormatPrice(currentPrice)}}

Free

{{FormatPrice(nonMemberPrice)}} List Price
This is your member pricing.
Notify Me About New Editions
Scope

Learning Objectives

  1. Appraise the knowledge base required of Molecular Oncology Laboratory Directors for optimal report interpretation and effective communication with clinical stakeholders (oncologists, genetic counselors, other providers). 
  2. Review the elements of building a successful and high-performing laboratory facility and testing and bioinformatics teams to support complex molecular oncology assays. 
  3. Identify best practices for sustainable laboratory quality and techniques to expand the reach and impact of your molecular oncology laboratory.

Intermediate: Refresher course. Some basic knowledge required, for the experienced staff technologist with some years of experience.

CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Speakers
Rong He, MD, Hematopathologist and Professor of Laboratory Medicine and Pathology, Mayo Clinic
Sertac Kip, MD, PhD, Medical Director, Clinical Pathology, PathGroup
Dan Jones, MD, PhD, Professor and Vice Chair of the Molecular Pathology Section, The Ohio State University
Honey Reddi, PhD, FACMG, SVP and Medical Director, Belay Diagnostics
Scope

Learning Objectives

  1. Appraise the knowledge base required of Molecular Oncology Laboratory Directors for optimal report interpretation and effective communication with clinical stakeholders (oncologists, genetic counselors, other providers). 
  2. Review the elements of building a successful and high-performing laboratory facility and testing and bioinformatics teams to support complex molecular oncology assays. 
  3. Identify best practices for sustainable laboratory quality and techniques to expand the reach and impact of your molecular oncology laboratory.

Intermediate: Refresher course. Some basic knowledge required, for the experienced staff technologist with some years of experience.

CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Speakers
Rong He, MD, Hematopathologist and Professor of Laboratory Medicine and Pathology, Mayo Clinic
Sertac Kip, MD, PhD, Medical Director, Clinical Pathology, PathGroup
Dan Jones, MD, PhD, Professor and Vice Chair of the Molecular Pathology Section, The Ohio State University
Honey Reddi, PhD, FACMG, SVP and Medical Director, Belay Diagnostics